Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,967 public trials 1,828 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Active, Not Recruiting

Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL

NCT04404283

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Central Alabama Research Birmingham, Alabama, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • University of California Davis Medical Center Sacramento, California, United States
  • Florida Cancer Specialists Bonita Springs, Florida, United States
View all 143 locations
View Trial Details
Active, Not Recruiting

Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease

NCT06125951

Conditions
Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +18 more
Locations
  • ACW Investigative Site 218 Carlsbad, California, United States
  • ACW Investigative Site 209 Sherman Oaks, California, United States
  • ACW Investigative Site 211 Denver, Colorado, United States
  • ACW Investigative Site 208 Englewood, Colorado, United States
View all 34 locations
View Trial Details
Active, Not Recruiting

A Phase II Study of Ibrutinib Plus FCR in Previously Untreated, Younger Patients With Chronic Lymphocytic Leukemia

NCT02251548

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • University of Miami Sylvester Comprehensive Cancer Center Coral Gables, Florida, United States
  • University of Miami Sylvester Comprehensive Cancer Center Deerfield Beach, Florida, United States
  • Unversity of Miami Sylvester Comprehensve Cancer Center Miami, Florida, United States
  • University of Kansas Cancer Center Westwood, Kansas, United States
View Trial Details
Active, Not Recruiting

Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia

NCT02143414

Conditions
Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, +23 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • John L McClellan Memorial Veterans Hospital Little Rock, Arkansas, United States
View all 196 locations
View Trial Details
Active, Not Recruiting

Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma

NCT04884035

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Local Institution - 162 Birmingham, Alabama, United States
  • Local Institution - 154 Scottsdale, Arizona, United States
  • Local Institution - 169 Duarte, California, United States
  • Local Institution - 160 Jacksonville, Florida, United States
View all 36 locations
View Trial Details
Active, Not Recruiting

A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies

NCT05589896

Conditions
Acute Biphenotypic Leukemia, Acute Leukemia, Acute Lymphoblastic Leukemia, +39 more
Locations
  • City of Hope Duarte, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Emory University - Winship Cancer Institute Atlanta, Georgia, United States
  • Henry Ford Cancer Institute Detroit, Michigan, United States
View Trial Details
Active, Not Recruiting

Valemetostat Tosylate (DS-3201b), an Enhancer of Zeste Homolog (EZH) 1/2 Dual Inhibitor, for Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01)

NCT04703192

Conditions
Adult T Cell Leukemia/Lymphoma, Hematologic Diseases, Hemic and Lymphatic Diseases, +15 more
Locations
  • City Of Hope National Medical Center Duarte, California, United States
  • Stanford University Medical Center - Cancer Clinical Trials Office - ONCOLOGY Palo Alto, California, United States
  • University of California San Francisco San Francisco, California, United States
  • University Of Colorado Cancer Center Aurora, Colorado, United States
View all 60 locations
View Trial Details

Related conditions